By contrast, gain-of-function mutations of NaV1.7 result in hyperexcitability of sensory neurons and underlie severe neuropathic pain conditions such as primary erythromelalgia (PE) and paroxysmal extreme pain disorder (PEPD) [14]. This evidence concerns the gene SCN9A and sodium channelopathy-related small fiber neuropathy.